Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of YM155 in Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Subjects
This study has been terminated.
( Futility boundary at interim analysis not met )
Study NCT00498914   Information provided by Astellas Pharma Inc
First Received: July 10, 2007   Last Updated: May 8, 2009   History of Changes

No Study Results Posted for this Study
About Study Results Reporting
  Study Status: This study has been terminated.
  Study Completion Date: April 2009
  Primary Completion Date: April 2009 (Final data collection date for primary outcome measure)